Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study
Author: O'Carrigan, B.
Fournier, M.
Olver, I.
Stockler, M.
Whitford, H.
Toner, G.
Thomson, D.
Davis, I.
Hanning, F.
Singhal, N.
Underhill, C.
Clingan, P.
Mcdonald, A.
Boland, A.
Grimison, P.
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Citation: Internal Medicine Journal, 2014; 44(8):813-817
Publisher: Blackwell Publishing
Issue Date: 2014
ISSN: 1444-0903
Statement of
B. O'Carrigan, M. Fournier, I. N. Olver, M. R. Stockler, H. Whitford, G. C. Toner, D. B. Thomson, I. D. Davis, F. Hanning, N. Singhal, C. Underhill, P. Clingan, A. McDonald, A. Boland, P. Grimison and Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Abstract: This is the first prospective study in a contemporary Australian/New Zealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life. Hormone assays from 54 evaluable patients in a prospective cohort study revealed biochemical hypogonadism in 18 patients (33%) and low-normal testosterone in 13 patients (24%). We found no association between testosterone levels and quality of life (all P > 0.05). Hypogonadal patients should be considered for testosterone replacement to prevent long-term morbidity.
Keywords: testicular cancer; hypogonadism; quality of life
Rights: © 2014 The Authors; Internal Medicine Journal © 2014 Royal Australasian College of Physicians
DOI: 10.1111/imj.12500
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.